Compare RLX Technology Inc (RLX) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
RLX Technology Inc vs Recursion Pharmaceuticals Inc — how do they compare? RLX Technology Inc trades at $2.03 (market cap $2.52B), while Recursion Pharmaceuticals Inc trades at $3.07 (market cap $1.53B). The key difference: RLX Technology Inc is the larger of the two by market cap, and RLX Technology Inc pays a 4.85% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| RLX | RXRX | |
|---|---|---|
Market Cap | $2.52B | $1.53B |
Sector | Technology | Health |
52-Week High | $2.73 | $6.79 |
52-Week Low | $1.79 | $2.84 |
Enterprise Value | $1.15B | $946.50M |
Dividend Yield | 4.85% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About RLX Technology Inc
RLX Technology Inc. is a leading e-vapor company in China, focusing on the research, development, and sale of e-vapor products. The company primarily operates under the RELX brand, offering a range of closed-system e-vapor products designed to deliver a high-quality user experience. RLX's business model is centered on product innovation, strong brand building, and a vast distribution network across China.
Read more on RLX →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
